Researchers from the Radboudumc and Radboud University will partner with social organisations to map how often young people with mild intellectual disabilities have psychological problems and how they can be treated. The project was recently awarded a subsidy of 1.5 million euro by ZonMw.
So far, little research has been carried out for and with young people with mild intellectual disabilities. That is why more research that looks into psychological problems in this group is urgently needed. The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) describes a mild intellectual disability as a ‘neurobiological developmental disorder in which there are limitations in intellectual and self-reliant functioning’.
No reliable figuresThere are no reliable figures in the Netherlands on the number of young people with this diagnosis. Additionally, hardly any information is available about the risk and protective factors that influence their functioning, despite the fact that there are large, leading population studies and clinical cohorts in the Netherlands with suitable data to gain insight into this.
In this new project, researchers will bundle and analyse data from these studies. They will use the results to optimize treatment and monitor patients with an innovative, person-oriented method: the iamYu app. iamYu is currently competing for the 2019 medical inspiration prize.
Joint initiativeThe project application was awarded the subsidy under the ZonMw grant call titled 'Long-term cohort study into early recognition and treatment in mental health care'. The project is a joint initiative of the Academic Workplace Kayak (in particular Dr. Mariëlle Dekker and Dr. Wouter Groen), main applicant Prof. Roy Otten (Radboud University, Pluryn), project leader Dr. Nanda Rommelse (Radboudumc, Karakter) , co-project leader Dr Catharina Hartman (UMCG), the aforementioned clinical institutions and leading population studies, and interest groups Zorgbelang Inclusive, LFB, and patient association KansPlus.
Related news items
'Stofwisselkracht' grant for Paola de Haas and Alessandra Cambi5 December 2019
Paola de Haas and Alessandra Cambi, theme Nanomedicine, have recently been awarded a grant from ‘Stichting Stofwisselkracht’ for their project entitled “Identification of immune-related symptoms in Congenital Disorders of Glycosylation”.read more
Newly appointed Junior Principal Clinicians3 December 2019
The appointed junior Principal Clinician for RIMLS are Heidi Zweers-van Essen and Jenneke Leentjens. These caregivers are at the forefront of renewing patient care and take the lead in the development and realization of the Radboudumc vision.read more
Large research grant for Radboudumc Health Academy & HAN3 December 2019
The Radboudumc Health Academy and the HAN receive a large research grant of 875.000 euro from the NRO (Nationaal Regieorgaan voor Onderwijsonderzoek) on developing flexible expertise.read more
Exploration meeting Academic Alliance on Oncology2 December 2019
Within the Academic Alliance, the Maastricht UMC+ and Radboudumc are already working together in several areas. And this is happening in more and more fields. On 27 November researchers from both umc's met during the fourth Exploration meeting, this time with the theme: Oncology.read more
How a DNA virus evades small RNA-based immunity29 November 2019
Gijs Overheul, Pascal Miesen and Ronald van Rij, theme Infectious diseases and global health, have elucidated the mechanism by which a DNA virus evades small RNA-based immunity of the host. They have published their results in PNAS.read more